CC
AGN

Curian Capital’s Allergan plc AGN Stock Holding History

Curian Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-18,946
Closed -$5.92M – 420
2015
Q4 		$5.92M Sell
18,946
-22,490
-54% -$6.7M 0.44% 40
2015
Q3 		$11.3M Buy
41,436
+3,924
+10% +$1.21M 0.3% 73
2015
Q2 		$11.4M Buy
37,512
+23,285
+164% +$6.94M 0.19% 133
2015
Q1 		$4.23M Sell
14,227
-2,568
-15% -$732K 0.07% 244
2014
Q4 		$4.32M Sell
16,795
-2,489
-13% -$622K 0.07% 236
2014
Q3 		$4.65M Sell
19,284
-7,716
-29% -$1.73M 0.08% 234
2014
Q2 		$6.02M Buy
27,000
+834
+3% +$173K 0.11% 211
2014
Q1 		$5.39M Buy
26,166
+17,051
+187% +$3.38M 0.1% 221
2013
Q4 		$1.53M Sell
9,115
-1,948
-18% -$305K 0.03% 320
2013
Q3 		$1.59M Buy
11,063
+883
+9% +$118K 0.03% 289
2013
Q2 		$1.28M Buy
+10,180
New +$1.15M 0.02% 309

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Curian Capital's AGN Position: Q1 2016 in Review

Curian Capital sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 18,946 shares — an estimated $5.92M sold.

Curian Capital first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $11.4M in Q2 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Curian Capital reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 18,946 Allergan plc shares in Q1 2016, an estimated $5.92M.
  • Curian Capital first reported a position in Allergan plc in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Allergan plc position peaked at $11.4M in Q2 2015.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.